CDTX vs NUE · rev $1.3M vs P/E 25, rev $7.08B
Cidara Therapeutics Inc (CDTX) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported NUE revenue for 2024-12-31 was $7.08B. Net income was $345.0M. Revenue was down 4.9% from 2024-09-28 to 2024-12-31. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
CDTX currently screens at market cap $6.96B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the CDTX and NUE stock pages for the full models.
Not investment advice.